Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
ibsolvmir
Press Release
Mar 13, 2020
TIKOMED Secures 5M Euro Funding for the Clinical Development of ILB™ and IBSOLVMIR®
Read More
Press Release
Mar 4, 2019
TFS International AB (TFS) Appointed CRO Representative for TIKOMED's Phase 2 Study in Clinical Islet Transplantation
Read More
Press Release
Feb 8, 2019
TIKOMED Successfully Closed Fundraising of 8 Million Euros
Read More
Press Release
Feb 6, 2019
Shadow Lake Group Appointed Strategic Advisor and Business Development Representative for the Licensing Process of IBsolvMIR® in Canada
Read More
Press Release
Nov 19, 2018
TIKOMED Granted Permission for Phase 2 Clinical Trial in Islet Cell Transplantation by the Swedish Medical Product Agency
Read More
First
Prev
1
Next
Last
